Europe approves SK Bioscience’s global COVID-19 vaccine plant
CDMO's site becomes the first vaccine production facility in South Korea to obtain EU GMP certification, allowing it to ship to Europe
South Korean CDMO SK Bioscience, which is manufacturing COVID-9 vaccines for both AstraZeneca and Novavax has received European Union Good Manufacturing Practice (EU GMP) certification for its Andong L House site.
The European Medicines Agency (EMA) certification, which approves the production facilities, processes, and quality systems for both AstraZeneca and Novavax COVID-19 vaccines being manufactured there, allows the CDMO to export vaccines to Europe.
The company said it is now making preparations to gain cGMP certification from the US Food and Drug Administration. Once it has successfully met that objective, SK Bioscience said it then plans to expand L House to accommodate growing demand by global companies for contract manufacturing services.
L House’s manufacturing facilities and R&D personnel are geared up for vaccine production, including activities such as cell cultivation, bacterial cultivation, gene recombination, and protein conjugation, so that even the newest vaccines can immediately enter mass production.
Last July, SK Bioscience agreed to manufacture the drug substance and the final product of the COVID-19 vaccine developed by AstraZeneca and Oxford University in the UK. This followed a Letter of Intent signed between SK Bioscience, AstraZeneca and South Korea's Ministry of Health and Welfare to accelerate vaccine manufacturing to help stem the pandemic in Korea and abroad.
In August last year, the company signed a CDMO contract to develop and produce Novavax’s COVID-19 vaccine. Earlier this year (February), SK Bioscience secured the rights to produce and sell Novavax's COVID-19 vaccine candidate, NVX-CoV2373, in South Korea.
SK Bioscience CEO Ahn Jae-yong said “the global vaccine demand is expected to increase explosively” and “we will accelerate our business expansion”.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance